ADC Therapeutics (ADCT)
(Delayed Data from NYSE)
$4.83 USD
+0.38 (8.54%)
Updated May 7, 2024 04:00 PM ET
After-Market: $4.83 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.56 |
EPS Last Quarter | -0.56 |
Last EPS Surprise | 0.00% |
ABR | 1.86 |
Earnings ESP
|
-2.70% |
---|---|
Current Year | -2.20 |
Next Year | -1.59 |
EPS (TTM) | -2.75 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 19.65M | 21.64M | 83.22M | 102.28M |
# of Estimates | 4 | 4 | 4 | 3 |
High Estimate | 20.70M | 24.31M | 91.87M | 108.23M |
Low Estimate | 18.56M | 19.27M | 76.69M | 97.01M |
Year ago Sales | 19.28M | 14.49M | 69.56M | 83.22M |
Year over Year Growth Est. | 1.90% | 49.36% | 19.64% | 22.90% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.56 | -0.55 | -2.20 | -1.59 |
# of Estimates | 4 | 4 | 4 | 3 |
Most Recent Consensus | -0.56 | -0.58 | -2.33 | NA |
High Estimate | -0.48 | -0.47 | -1.89 | -1.51 |
Low Estimate | -0.65 | -0.63 | -2.53 | -1.72 |
Year ago EPS | -0.58 | -0.58 | -2.94 | -2.20 |
Year over Year Growth Est. | 3.45% | 5.17% | 25.17% | 27.35% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 0 |
Down Last 60 Days | 2 | 2 | 3 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.56 | -0.55 | -2.20 | -1.59 |
7 Days Ago | -0.58 | -0.57 | -2.20 | -1.59 |
30 Days Ago | -0.57 | -0.57 | -2.19 | -1.64 |
60 Days Ago | -0.47 | -0.47 | -1.92 | -1.49 |
90 Days Ago | -0.47 | -0.47 | -2.07 | -1.50 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.57 | -0.56 | -2.43 | -1.55 |
Zacks Consensus Estimate | -0.56 | -0.55 | -2.20 | -1.59 |
Earnings ESP | -2.70% | -3.36% | -10.71% | 2.72% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.56 | -1.03 | -0.58 | -0.58 | NA |
Estimate | -0.56 | -0.47 | -0.61 | -0.44 | NA |
Difference | 0.00 | -0.56 | 0.03 | -0.14 | -0.17 |
Surprise | 0.00% | -119.15% | 4.92% | -31.82% | -36.51% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more